[Federal Register Volume 85, Number 209 (Wednesday, October 28, 2020)]
[Notices]
[Pages 68328-68329]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-23804]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Solicitation of Nominations for Appointment to the Lead Exposure 
and Prevention Advisory Committee (LEPAC)

ACTION: Notice.

-----------------------------------------------------------------------

SUMMARY: The Centers for Disease Control and Prevention (CDC) is 
soliciting nominations for membership on the LEPAC. The LEPAC consists 
of 15 Federal and non-Federal experts in fields associated with lead 
screening, the prevention of lead exposure, and services for 
individuals and communities affected by lead exposure. Nominations are 
being sought for individuals who have expertise and qualifications 
necessary to contribute to the accomplishment of the committee's 
objectives. Nominees will be selected based on expertise in the fields 
of epidemiology, toxicology, mental health, pediatrics, early childhood 
education, special education, diet and nutrition, and environmental 
health. Members may be invited to serve for three-year terms. Selection 
of members is based on candidates' qualifications to contribute to the 
accomplishment of LEPAC objectives.

DATES: Nominations for membership on the LEPAC must be received no 
later than December 15, 2021. Packages received after this time will 
not be considered for the current membership cycle.

ADDRESSES: All nominations should be emailed to [email protected].

FOR FURTHER INFORMATION CONTACT: Ms. Perri Ruckart, M.P.H., Designated 
Federal Officer, National Center for Environmental Health, CDC, 4770 
Buford Highway, Atlanta, GA 30341, 770-488-3300, [email protected].

SUPPLEMENTARY INFORMATION: The members of this committee are selected 
by the Secretary of the U.S. Department of Health and Human Services 
(HHS). The committee advises the Secretary, HHS and the Director, 
Centers for Disease Control and Prevention/Administrator, Agency for 
Toxic Substances and Disease Registry on a range of activities to 
include: (1) Review of Federal programs and services available to 
individuals and communities exposed to lead; (2) review of the current 
research on lead exposure to identify additional research needs; (3) 
review of and identification of best practices, or the need for best 
practices regarding lead screening and the prevention of lead exposure; 
(4) identification of effective services, including services relating 
to healthcare, education, and nutrition for individuals and communities 
affected by lead exposure and lead poisoning, including in consultation 
with, as appropriate, the lead exposure registry as established in 
Public Law 114-322 Section 2203(b) (42 U.S.C. 300j-27); and (5) 
undertaking of any other review or activities that the Secretary 
determines to be appropriate.

[[Page 68329]]

    Annually as determined necessary by the Secretary or as required by 
Congress, the committee shall submit a report to include: (1) An 
evaluation of the effectiveness of the Federal programs and services 
available to individuals and communities exposed to lead; (2) an 
evaluation of additional lead exposure research needs; (3) an 
assessment of any effective screening methods or best practices used or 
developed to prevent or screen for lead exposure; (4) input and 
recommendations for improved access to effective services relating to 
health care, education, or nutrition for individuals and communities 
impacted by lead exposure; and (5) any other recommendations for 
communities affected by lead exposure, as appropriate.
    At least half of the committee will consist of Federal 
representatives from a range of agencies that may include the 
Department of Housing and Urban Development; the Environmental 
Protection Agency; the Consumer Product Safety Commission; the Centers 
for Medicare and Medicaid Services; the Health Resources and Services 
Administration; the Food and Drug Administration; the U.S. Department 
of Agriculture; the Occupational Safety and Health Administration; the 
National Institute of Environmental Health Sciences; the U.S. 
Geological Survey; and such additional federal, state, tribal, and 
local public and private officials as the Secretary deems necessary for 
the committee to carry out its function. The rest of the committee will 
consist of non-Federal members. Only non-Federal members are being 
solicited with this announcement.
    The U.S. Department of Health and Human Services policy stipulates 
that committee membership be balanced in terms of points of view 
represented and the committee's function. Appointments shall be made 
without discrimination on the basis of age, race, ethnicity, gender, 
sexual orientation, gender identity, HIV status, disability, and 
cultural, religious, or socioeconomic status. Nominees must be U.S. 
citizens and cannot be full-time employees of the U.S. Government. 
Current participation on federal workgroups or prior experience serving 
on a federal advisory committee does not disqualify a candidate; 
however, HHS policy is to avoid excessive individual service on 
advisory committees and multiple committee memberships.
    Committee members are Special Government Employees, requiring the 
filing of financial disclosure reports at the beginning and annually 
during their terms. CDC reviews potential candidates for LEPAC 
membership each year and provides a slate of nominees for consideration 
to the Secretary of HHS for final selection. HHS notifies selected 
candidates of their appointment as soon as the HHS selection process is 
completed. Note that the need for different expertise varies from year 
to year and a candidate who is not selected in one year may be 
reconsidered in a subsequent year. Nominees must be U.S. citizens, and 
cannot be full-time employees of the U.S. Government.
    Candidates should submit the following items:
     Current curriculum vitae, including complete contact 
information (telephone numbers, mailing address, email address).
     At least one letter of recommendation from person(s) not 
employed by the U.S. Department of Health and Human Services. 
(Candidates may submit letter(s) from current HHS employees if they 
wish, but at least one letter must be submitted by a person not 
employed by an HHS agency (e.g., CDC, NIH, FDA, etc.)
    Nominations may be submitted by the candidate him- or herself or by 
the person/organization recommending the candidate.
    The Director, Strategic Business Initiatives Unit, Office of the 
Chief Operating Officer, Centers for Disease Control and Prevention, 
has been delegated the authority to sign Federal Register notices 
pertaining to announcements of meetings and other committee management 
activities, for both the Centers for Disease Control and Prevention and 
the Agency for Toxic Substances and Disease Registry.

Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief 
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2020-23804 Filed 10-27-20; 8:45 am]
BILLING CODE 4163-18-P